UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience

BMC cancer, 2023-09, Vol.23 (1), p.1-907, Article 907

2023

Volltextzugriff (PDF)

Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling

Oncogene, 2011-06, Vol.30 (24), p.2730-2740

2011

Volltextzugriff (PDF)

CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling

Oncogene, 2016-07, Vol.35 (30), p.3944-3954

2016

Volltextzugriff (PDF)

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients

Acta oncologica, 2018-07, Vol.57 (7), p.958-964

2018

Volltextzugriff (PDF)

Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle

Cell death and differentiation, 2011-08, Vol.18 (8), p.1305-1315

2011

Volltextzugriff (PDF)

CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients

European journal of cancer (1990), 2015-11, Vol.51 (17), p.2624-2633

2015

Volltextzugriff (PDF)

Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy

The pharmacogenomics journal, 2012-12, Vol.12 (6), p.476-483

2012

Volltextzugriff (PDF)

1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

Oncogene, 2012-03, Vol.31 (10), p.1287-1298

2012

Volltextzugriff (PDF)

Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma

Oncogene, 2011-05, Vol.30 (18), p.2173-2180

2011

Volltextzugriff (PDF)

CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity

Oncogene, 2014-04, Vol.33 (15), p.1912-1921

2014

Volltextzugriff (PDF)

Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression

Annals of oncology, 2014-10, Vol.25 (10), p.2080-2086

2014

Volltextzugriff (PDF)

Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model

BMC medical genomics, 2015-06, Vol.8 (1), p.34-34, Article 34

2015

Volltextzugriff (PDF)

Anticancer effects of zoledronic acid against human osteosarcoma cells

Journal of orthopaedic research, 2006-06, Vol.24 (6), p.1145-1152

2006

Volltextzugriff (PDF)

Targeted therapies in bone sarcomas

Current cancer drug targets, 2009-11, Vol.9 (7), p.843-853

2009

Volltextzugriff (PDF)

Antiproliferative activity of CCN3: Involvement of the C-terminal module and post-translational regulation

Journal of cellular biochemistry, 2007-08, Vol.101 (6), p.1475-1491

2007

Volltextzugriff (PDF)

Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma

Annals of oncology, 2008-08, Vol.19 (8), p.1500-1508

2008

Volltextzugriff (PDF)

Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome

Annals of oncology, 2016-09, Vol.27 (9), p.1788-1793

2016

Volltextzugriff (PDF)

CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity

Oncogene, 2007-10, Vol.26 (46), p.6604-6618

2007

Volltextzugriff (PDF)

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells

Annals of oncology, 2004-01, Vol.15 (1), p.151-160

2004

Volltextzugriff (PDF)

680: miR-187 targets the androgen-regulated gene ALDH1A3 in prostate cancer

European journal of cancer (1990), 2014-07, Vol.50, p.S163-S163

2014

Volltextzugriff (PDF)

Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma

Cytogenetic and genome research, 2007-01, Vol.119 (1-2), p.21-26

2007

Volltextzugriff (PDF)

954 Immunophenotype and CD99 Expression Patterns of Human Mesenchymal Stem Cells and Their Implication in Ewing Sarcoma Genesis, Biology and Treatment

European journal of cancer (1990), 2012-07, Vol.48, p.S229-S230

2012

Volltextzugriff (PDF)

CD99: A new mediator of osteoblastogenesis

Bone (New York, N.Y.), 2011-05, Vol.48, p.S258-S258

2011

Volltextzugriff (PDF)

OR8-6: The anti-IGF signaling agents increase the efficacy of Trabectedin in Ewing sarcoma

Growth hormone & IGF research, 2014-10, Vol.24, p.S23-S23

2014

Volltextzugriff (PDF)

P03-13 Preclinical effectiveness of metformin in Ewing sarcoma

Growth hormone & IGF research, 2012-10, Vol.22, p.S75-S76

2012

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(148)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(97)
Life Sciences & Biomedicine
(97)
Science & Technology
(97)
Oncology
(64)
Biological And Medical Sciences
(61)
Medical Sciences
(54)
Tumor Cells, Cultured
(38)
Bone Neoplasms - Pathology
(33)
Female
(33)
Diseases Of The Osteoarticular System
(32)
Tumors Of Striated Muscle And Skeleton
(32)
Animals
(31)
Tumors
(30)
Male
(29)
Osteosarcoma - Pathology
(28)
Mice
(27)
Osteosarcoma
(27)
Cell Biology
(24)
Bone Neoplasms - Genetics
(23)
Osteosarcoma - Drug Therapy
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience

Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling

CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients

Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle

CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients

Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy

1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma

CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity

Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression

Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model

Anticancer effects of zoledronic acid against human osteosarcoma cells

Targeted therapies in bone sarcomas

Antiproliferative activity of CCN3: Involvement of the C-terminal module and post-translational regulation

Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma

Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome

CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells

680: miR-187 targets the androgen-regulated gene ALDH1A3 in prostate cancer

Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma

954 Immunophenotype and CD99 Expression Patterns of Human Mesenchymal Stem Cells and Their Implication in Ewing Sarcoma Genesis, Biology and Treatment

CD99: A new mediator of osteoblastogenesis

OR8-6: The anti-IGF signaling agents increase the efficacy of Trabectedin in Ewing sarcoma

P03-13 Preclinical effectiveness of metformin in Ewing sarcoma

Suchergebnisse filtern